Entered into a Joint Venture Agreement (“JVA”) on August 31, 2025, with an object to utilise the technological
As filed · Agreements
BusinessWatchNotablemateriality 62 out of 100
What happened
Factentered into a Joint Venture Agreement (“JVA”) on August 31, 2025, with an object to utilise the technological. Both the JV Partners have agreed that NIL shall own 80% majority stake in NML, while MIL shall hold. remaining 20% in NML by contributing USD 20 million.
Why it matters
CapitSignal interpretationA joint venture commits capital and management time to an asset the company only part-owns.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
ContradictedEarlierQ1 FY27
Pakhajan Phase 2 is budgeted at INR 1,367 crore with completion expected by March 2027
NowQ1 FY27
Dahej Phase 1 project cost stands at INR 428 crore with target completion by February 2027, while Pakhajan Phase 2 is budgeted at INR 1,367 crore with completion expected by March 2027
Change
FactFact conflict
Implication
CapitSignal interpretationThe current statement introduces a new project, Dahej Phase 1, with a cost of INR 428 crore, which was not mentioned in the earlier statement. This creates a conflict regarding the focus of the capex discussion.
Watch next
Fact- Capital commitment and ownership split
- Whether it is consolidated or equity-accounted
- 1,000 MT to be commissioned by H2 FY27 (management committed by H2 FY27)
- Looking ahead, as the replacement Dahej plant begins regular commercial operations and Neogen Ionics (NIL) cap (management committed by H2 FY27)
Evidence
- Neogen Chemicals Limited has informed the Exchange about Agreements(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q4 FY26
How CapitSignal classified this
- Reasoning:
- JOINT_VENTURE base 54; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%